and/or "white-coat" BP elevation. 4, 5 These 2 factors result in frequent overestimation of usual patient BP and consequent misdiagnosis and overtreatment of hypertension in 20% to 65% of persons with elevated office BP. 5 Current US and international guidelines emphasize the necessity of accurate BP measurement in and out of the office, and this necessity will be magnified if the lower BP goals recommended by some guidelines are implemented. 6 -8 Most current guidelines recommend OBPM to screen for hypertension with confirmation of the diagnosis by out-of-office BP monitoring. 6 -11 A 24-hour ambulatory blood pressure However, ABPM is infrequently used in the United States 12 due to limited availability 13 and reimbursement 14, 15 and clinician unfamiliarity with its utility. 14 In contrast, home blood pressure measurement (HBPM) is currently used by about 50% of US hypertensive adults 16 and 34% to 70% of US primary care clinicians. 17 HBPM combined with 1 or more cointerventions (eg, clinician-guided medication titration, pharmacist/nurse comanagement with or without telemonitoring or digital health platforms, or algorithm-guided patient self-titration of medication) lowers BP and improves hypertension control rates in research studies. 18 -22 Important barriers to effective implementation of HBPM into general US primary care practice include the considerable expense of interventions such as telemonitoring systems or adding staff for comanagement, the need for clinic redesign to incorporate HBPM training into a busy clinic setting, and concern about the accuracy of HBPM performed by patients in nonresearch settings. 14, [23] [24] [25] [26] [27] [28] [29] Automated office blood pressure measurement (AOBP), the performance and averaging of 3 to 5 sequential automated BP measurements by a validated device while patients rest alone 30 , may reduce white-coat BP elevation and decrease the need for subsequent out-of-office BP measurement. 31, 32 In patients with initially elevated office BP, AOBP is more time efficient than performing 3 guidelinerecommended observed office BP measurements. AOBP requires 4 to 7 minutes instead of 8 to 11 minutes, and staff can attend to other duties during this time. AOBP is the recommended approach to OBPM by Hypertension Canada 7 and by the National Heart Foundation of Australia. 6, 33 The goal of our study was to effectively implement AOBP and HBPM measurement programs in a primary care clinic setting to detect white-coat BP elevation, reduce unnecessary antihypertensive therapy, and improve hypertension control without the use of dedicated research staff, space, or time. We also evaluated metrics critical to sustainability of the program, including estimates of staff time, patient/ provider satisfaction, and patient engagement in HBPM.
Methods

Study Setting
This was a pragmatic, prospective, observational study implementing a new AOBP and HBPM program in a university, hospital-based, primary care internal medicine clinic with approximately 15,000 patient visits per year in Salt Lake City, Utah. The study was conducted over 13 months from December, 2015 through December, 2016, and was reviewed and deemed exempt by the Institutional Review Board of the University of Utah Medical Center.
Study Population
Patients were eligible for the study if their clinic visit BP was elevated as defined below, and they met the following criteria: 1) no prior diagnosis of hypertension, or treated hypertension on a stable dose of antihypertensive medication; 2) considered suitable by their primary care clinician for HBPM without known adherence issues, cognitive impairments, severe depression, unstable cardiovascular disease, end-stage renal disease or dialysis treatment, or BP Ն 200/120 mm Hg; 3) age Ն 18 years, not pregnant or lactating, adequate verbal or written English fluency; and 4) agreed to baseline HBPM education and to follow the recommended HBPM protocol. Patients with elevated clinic BP not enrolled during the 13 months of the study did not meet the entry criteria listed above, declined participation in the HBPM program, or were not approached for participation due to time constraints in the clinic. The nonenrolled patients were characterized for comparison with enrolled patients.
Study Design
The intended and finally implemented study designs are summarized in Figure 1 . All BP measurements in the study were performed by clinic medical assistants (MAs) as described below in the BP measurement sections. By design, all clinic patients were to have a single, guideline-quality, observed, automated BP measurement performed by the MA. Those with BP Ն140/90 mm Hg were then to undergo AOBP with 3 sequential automated BP measurements performed with the patient alone in the examination room. Those with AOBP Ն135/85 mm Hg 7 were to be asked to consider participation in the HBPM program. However, in the early months of the study, this protocol was implemented by some, but not all the clinic MAs. As a result, 53 and 40 patients respectively, were mistakenly enrolled onto the HBPM program based on either a single, observed, automated BP measurement Ն140/90 mm Hg or based on the average of 3 observed automated BP measurements Ն140/90 mm Hg. Ninety subjects were enrolled during the course of the study based on AOBP Ն135/85 mm Hg. Based on initial HBPM results and hypertension status (prior or no prior hypertension diagnosis) patients were categorized into 4 groups (Figure 1 ). Patients not currently receiving antihypertensive medications whose average home BP was Ն135/85 mm Hg were diagnosed with new hypertension, and those with average home BP Ͻ135/85 mm Hg were diagnosed with white-coat hypertension. 7, 10, 33 Patients currently receiving antihypertensive medication were diagnosed with uncontrolled hypertension if average home BP was Ն135/85 mm Hg and with white-coat BP elevation if Ͻ135/85 mm Hg.
Patients diagnosed with new hypertension or uncontrolled hypertension based on home BP measurement had antihypertensive medications initiated/ adjusted every 2 to 4 weeks by the clinic pharmacist during the first 9 months of the study and by the primary care physician during the last 4 months of the study (after departure of the clinic pharmacist) until home BP was controlled below 135/85 mm Hg.
Office BP Measurement
Clinic MAs and clinician staff were trained in a dedicated didactic session to perform guidelinequality office BP measurement according to current guidelines for clinical care 34 and hypertension research studies. 35 All office BP measurements were performed using a validated oscillometric upper arm automated device, the Omron HEM-907XL 36 device that was used in the ACCORD 37 and SPRINT 38 hypertension trials, with an appropriate cuff size for midarm circumference. Before 1 to 3 observed OBPMs performed at 1-minute intervals, patients rested 5 minutes, seated in a chair with back supported, cuff at midsternal level, arm supported on a flat surface, feet flat on the floor, with no conversation during measurements. Correct measurement technique was monitored and reinforced during the study.
AOBP was performed with patients entirely alone in the examination room using the Omron HEM-907XL device set to average 3 sequential measurements at 1 minute intervals. According to current recommendations, a 5-minute rest period was not used before AOBP measurements. 7 Otherwise, the techniques noted above were followed. An average AOBP Ն135/85 mm Hg was used as an entry criteria to the study as this value corresponds to a daytime ABPM Ն135/85 mm Hg. 7, 30, 32 Home BP Measurement Clinic staff were trained in recommended HBPM technique in a dedicated didactic session. 39, 40 Patient HBPM training included individual demonstration with observed confirmation of correct technique, provision of a written instruction summary sheet for home review, and an electronic link to an HBPM video to view in clinic or at home (Hypertension Canada: http://www.youtube.com/watch? vϭeqadjdX5XU9Y7ϩϭ15s). Patients were instructed to take their BP twice daily after resting quietly in a chair for 5 minutes, legs uncrossed and feet flat on the floor, when under no subjective stress, before breakfast and before supper or at bedtime but before any BP medication intake. They were asked to collect 2 or 3 BP measurements at 1-minute intervals, for 5 consecutive days, and then report the average of the 20 readings to the clinic pharmacist or medical staff via telephone, electronically through the electronic health record (EHR) secure messaging system, or in-person visits. 41, 42 Proper HBPM technique was reinforced during subsequent office visits and phone calls.
Eighty-four enrolled patients were loaned a validated HBPM device, the Omron BP786N 43 , which contains Bluetooth technology, a cuff that automatically adjusts to arms 9 to 17 inches in circumference, and has the capability to automatically take and average 3 BP measurements at 1-minute intervals. Ninety-nine enrolled patients were allowed to use their own HBPM devices given that the monitors had been validated by 1 or more international protocols (www.medaval.org). The accuracy of both loaned and patient-owned devices was confirmed against the office Omron HEM-907XL according to prior recommendations. 44 
Patient and Provider Questionnaires
Questionnaires were designed by the study investigators to determine patient and staff satisfaction with the program, time spent on the program, and intentions to continue with the program in the future. Questionnaire items were determined by face validity, and satisfaction was measured on a 5-point Likert scale (strongly agree-strongly disagree; Appendices 1 and 2). Strongly agree/agree and strongly disagree/disagree categories were collapsed when presenting results. Patient questionnaires were mailed to patients in 2 waves and returned anonymously; the second survey wave included a $5 compensation for completion. Provider questionnaires were distributed in clinic and returned anonymously. A separate anonymous questionnaire was mailed to patients to self-assess their adherence to the recommended techniques of HBPM (Appendix 3). In this questionnaire, we assessed domains of proper HBPM that corresponded to those in the HBPM instructions provided to patients.
Time Estimates for Staff
Clinic staff were asked estimate the average time per patient needed to perform project clinical tasks: unobserved AOBP measurement, patient training for HBPM, HBPM device accuracy assessment, EHR documentation of AOBP/HBPM data, and transmission of HBPM data to the clinician.
Statistical Analysis
Descriptive statistics were collected for patient characteristics, including baseline systolic and diastolic BP. Diagnoses determined after receipt of initial HBPM results were stratified by OBPM technique and a Fisher's exact test was used to determine whether the proportion of diagnoses differed by OBPM technique.
Results
Characteristics of Enrolled Patients
Characteristics of the 183 enrolled patients and 1326 nonenrolled patients with elevated BP seen in our clinic during the same time period are listed in Table 1 . The average age of patients enrolled was 59.7 years, of which 56% were males and 90% were white. Comorbid medical conditions included an existing diagnosis of hypertension (65%), hyperlipidemia (52%), cardiovascular disease (26%), and diabetes (20%). Patients with previously diagnosed hypertension used an average of 1.8 antihypertensive medications. Enrolled patients were similar to nonenrolled patients.
The average clinic BP of the 183 enrolled patients was 147. (20) 326 (25) Cardiovascular disease, n (%) 47 (26) 424 (32) Hyperlipidemia, n (%) 95 (52) 757 (57) Chronic kidney disease*, n (%) 17 (9) 160 (12) Hypertension diagnosis in EHR, n (%) 119 ( subgroup, and 129.9/82.9 mm Hg for the single observed BP measurement subgroup. Of patients with elevated office BP and not on medication at enrollment, 29 (35%) were found to have white-coat hypertension with average home BP Ͻ135/85 mm Hg (Table 2A ). The prevalence of white-coat hypertension did not significantly differ according to the method of OBPM: 21% for the observed average of 3 measurements, 33% for unobserved AOBP, and 48% for single observed BP (P ϭ .39). Forty-five patients (54%) were diagnosed with new hypertension by HBPM, while 10 patients (12%) never provided HBPM results to the clinic.
Of patients on antihypertensive medication at enrollment, 37 (37%) were found to have whitecoat BP elevation with average home BP Ͻ135/85 mm Hg (Table 2B) . Again, the frequency of whitecoat BP elevation did not differ according to the method of OBPM: white-coat BP elevation was diagnosed in 24% of patients with an observed average of 3 BP measurements, 42% of patients with unobserved AOBP, and 40% of patients with a single observed BP measurement (P ϭ .19). Fiftythree patients (54%) were diagnosed with uncontrolled hypertension, while 9 patients (9%) did not provide HBPM results to the clinic.
Rates of Home BP Control in Patients with New Diagnosis of Hypertension or Uncontrolled Hypertension
During the course of the 13 month study, 37 of 45 (82%) patients with a new diagnosis of hypertension provided additional serial HBPM results to facilitate initiation and adjustment of antihypertensive medications. Nineteen patients (51%) achieved average home BP Ͻ135/85 mm Hg. Thirty-nine of 53 patients (74%) with uncontrolled hypertension provided serial HBPM results, and 18 of the 39 patients (46%) achieved average home BP Ͻ135/85 mm Hg. We were not able to obtain serial HBPM measurements in 22 of 98 hypertensive patients (22%) despite repeated attempts to contact them.
Provider/Staff Satisfaction Questionnaires and Time Estimates
Nineteen staff members received and completed the anonymous questionnaire (12 physicians in- 22 (52) 12 (63) 11 (48) White coat HTN, n (%) 14 (33) 4 (21) 11 (48) Diagnosis unknown (no initial HBPM received), n (%) 6 (14) 3 (16) 1 (4) Fisher's exact test was used to determine whether the proportion of diagnoses differed by OBPM technique (P ϭ .39). AOBP, automated office blood pressure; BP, blood pressure; HBPM, home blood pressure measurement; OBPM, office blood pressure measurement; HTN, hypertension. Existing uncontrolled HTN, n (%) 21 (44) 15 (71) 17 (57) White-coat BP elevation, n (%) 20 (42) 5 (24) 12 (40) Unknown (no initial HBPM received), n (%)
7 (14) 1 (5) 1 (3) Fisher's exact test was used to determine whether the proportion of diagnoses differed by OBPM technique (P ϭ .19). AOBP, automated office blood pressure; BP, blood pressure; HBPM, home blood pressure measurement; OBPM, office blood pressure measurement; HTN, hypertension.
cluding 10 resident physicians, 5 MAs, and 2 pharmacists). Only a small minority (16%) agreed that the AOBP/HBPM program required excessive time/effort; 68% disagreed (Supplemental Table  1 ). Eighty-four percent of clinic staff respondents indicated they were adequately trained to effectively educate patients in proper HBPM techniques, and 89% estimated spending 1 to 15 minutes per patient on the project. Notably, 2 respondents estimated spending 31 to 45 minutes per patient on the project. The MA estimates of the specific time requirements for various tasks in the AOBP/HBPM program are listed in Table 3 . Overall, 68% of clinic staff agreed that the program positively influenced hypertension management in the clinic.
Patient Satisfaction and HBPM Technique Questionnaires
The patient satisfaction questionnaire had a 45% response rate. Ninety-one percent of respondents indicated that the instructions for HBPM were "easy to follow" and 63% spent fewer than 15 minutes per day measuring BP on BP measurement days (Supplemental Table 2 ). Over 80% of respondents agreed that the project made them more involved in the care of their hypertension and improved their confidence to accurately measure their BP. Still, 26% of respondents did not plan to continue home BP monitoring after project completion. The patient technique questionnaire had a 43% response rate. Despite prior intensive HBPM education, a substantial number of patients continued to use incorrect BP measurement technique that could invalidate their HBPM results. Overall, only a small minority (13%) of respondents indicated proper/desired technique in all domains. Errors were most common in incorrect/inadequate rest period before measurement (52%); failure to send results to clinic (33%); and failure to refrain from other activity during measurement (29%).
Discussion
This initiative demonstrates that an AOBP/HBPM program can be effectively implemented in a nonresearch primary care setting to detect white-coat BP elevation and reduce unnecessary antihypertensive therapy with favorable patient/provider satisfaction and patient engagement in HBPM. However, there are some important barriers to implementation that need to be overcome to maximize program success.
About one third of our patients with elevated clinic BP had white-coat hypertension in untreated patients or white-coat BP elevation in previously treated patients, similar to the 15% to 30% prevalence of white-coat hypertension in untreated patients and 25% to 38% prevalence of white-coat BP elevation in treated patients found in prior studies. 4, 5, 45 AOBP has been demonstrated in multiple studies to reduce white-coat BP elevation and the subsequent need for out-of-office BP measurement 30 -32 but we could not confirm its utility in our study. While initial average home BP was somewhat higher in the unobserved AOBP subgroup than in the 2 observed BP measurement subgroups (133.1 mm Hg vs 131.9 mm Hg and 129.9 mm Hg), there was no significant difference among the 3 subgroups in the prevalence of whitecoat BP elevation. This finding may have been related to our small sample size.
Initiation and/or intensification of antihypertensive medications in patients with elevated home BP who submitted subsequent HBPM results controlled home BP Ͻ135/85 mm Hg in 51% and 46% of new and uncontrolled hypertensive patients, respectively. These control rates are similar to the 6-to-12-month hypertension control rates of 54% to 71% noted in 4 HBPM studies using telemonitoring with independent pharmacist comanagement 18, 19, 46, 47 and the 53% 12-month control rate in a study without telemonitoring that used direct HBPM feedback to primary care clinicians. 48 Primary care clinicians have expressed several concerns about implementing AOBP and HBPM in a nonresearch setting: whether an AOBP/HBPM program can be efficiently incorporated into daily clinical practice; whether patients will follow through with HBPM despite its substantial time/ effort commitment; and whether patients will perform HBPM with sufficient accuracy. 14, 49 With respect to the first concern about clinic efficiency, 68% of our clinic staff reported that the AOBP/ HBPM program positively affected hypertension management and did not require excessive time/ effort, an interpretation supported by the estimated time commitments noted in Table 3 . While we did not objectively assess staff time commitments to the AOBP/HBPM program, 2 out of 19 respondents reported excessive time commitments of 31 to 45 minutes per patient. Perceived time burden may be more important than actual time commitment for program success. However, despite initial staff education about AOBP purpose and technique, MAs continued to perform observed BP measurements on some patients rather than unobserved AOBP early in the study. Effective educational materials along with frequent reinforcement and monitoring may be necessary to affect this culture-shift in OBPM.
Most of our enrolled patients followed through with HBPM as 90% provided requested initial HBPM results, and 74% of questionnaire respondents indicated they would continue HBPM in the future. Still, even with provision of a free loaned HBPM monitor and frequent telephone followup, 10% of enrolled patients provided no initial HBPM results, 22% provided no subsequent HBPM results despite their elevated home BP, and 26% of questionnaire respondents did not plan to continue using HBPM. Prior HBPM studies note that up to 20% of patients decline to initiate HBPM 18 and report rates of submission of HBPM results of 70% to 91% with dedicated pharmacist support 46,47 but as low as 32% to 36% when such support was unavailable. 27, 48 Studies are needed to determine which patients are more likely not to complete HBPM and whether directed intensive patient education and shared decision making can minimize this barrier.
Potentially inaccurate HBPM results concern primary care clinicians and contribute to clinician therapeutic inertia to intensify antihypertensive therapy. 14, 50 Patient technique questionnaire results indicate continued patient errors in HBPM technique despite intensive education that could reduce HBPM accuracy and therefore undermine primary care clinician confidence in the HBPM intervention. Our "perfect adherence" results are similar to or even lower than those of previous studies that found only 18% to 53% of patients were sufficiently adherent to HBPM procedures to assure reasonable accuracy. 26, 27 Active patient education interventions and frequent reinforcement may be necessary to assure quality HBPM measurement, and we identified areas on which additional patient education could be focused: rest time, transmission of results, and avoiding other activities during measurement. [51] [52] [53] Study strengths include a representative adult primary care population in a real-world clinic setting without use of dedicated research staff, time, or space. Telemonitoring was not used, and patients did not require computer access to report HBPM results. Observed office BP and AOBP were performed using a validated device according to current guideline recommendations 7, 34 HBPM devices and BP measurement protocols adhered to current guidelines 39 -44 , and HBPM training was intensive and frequently reinforced.
Study limitations include a single-center setting with limited minority population. Although we did use a clinical pharmacist, who had been previously assigned to the clinic for the first 9 months of the 13-month study, the primary care clinicians assumed all her duties for patient followup for the final 4 months. There are potential limitations to using HBPM rather than 24-hour ABPM to diagnose hypertension. HBPM is subject to inaccurate patient measurement technique and underreporting of high HBPM results. We could not monitor for underreporting as most patients reported HBPM results by telephone or the EHR. We did not use telemonitoring due to expense and did not require patients to bring in devices for download to minimize patient burden. HBPM may misclassify approximately 25% of true hypertension patients as having white-coat BP elevation if 24-hour ABPM is used as the standard diagnostic test 54, 55 ; however, it remains uncertain whether 24-hour ABPM indeed provides superior prediction of cardiovascular risk compared with HBPM. 56 While adjusting antihypertensive therapy according to HBPM results rather than office BP has not yet been proven by a randomized trial to provide superior reduction of cardiovascular events, HBPM does provide superior cardiovascular event prediction in treated hypertension patients.
57
Conclusion
An AOBP/HBPM initiative in a nonresearch setting successfully detected white-coat BP elevation in one third of patients with elevated office BP and facilitated hypertension control in one half of patients with elevated home BP who provided follow-up data. AOBP did not clearly reduce whitecoat BP elevation in our population, and there were early-on challenges in having staff consistently perform AOBP.
The program was well accepted with respect to feasibility and efficiency by most clinic staff and patients. Barriers to program implementation included a temporary adjustment period for clinic staff to correctly use AOBP, about one fifth of patients failing to provide follow-up HBPM results, and many patients reporting incorrect HBPM technique despite intensive education. Future research should identify those patients most likely to perform and benefit from HBPM and determine how to best use shared decision making to optimize HBPM performance.
